StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX stock opened at $0.02 on Monday. The firm’s fifty day simple moving average is $0.14 and its 200-day simple moving […]
Athersys (NASDAQ:ATHX – Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.15) EPS for the quarter, reports. Athersys Price Performance ATHX stock remained flat at $0.02 during mid-day trading on Friday. 1,135,773 shares of the company’s stock were exchanged, compared to its average volume of 1,552,183. The stock has […]
Athersys (NASDAQ:ATHX – Get Free Report) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.15) EPS for the quarter, reports. Athersys Stock Performance ATHX stock remained flat at $0.02 on Friday. 1,135,773 shares of the company traded hands, compared to its average volume of 1,552,183. The firm’s 50-day simple moving average is […]
StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance Shares of ATHX opened at $0.02 on Friday. The firm’s 50 day moving average is $0.20 and its 200-day moving […]
StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance NASDAQ ATHX opened at $0.02 on Friday. The firm has a market cap of $439,087.50, a price-to-earnings ratio of -0.01 and a beta […]